See the source article by following the link below:
Scientists develop a pioneering new methodology to study immune cells within tumor using transcriptomic profiling. They show how immune cells can be both good and bad in different cancers. This could aid in improving immunotherapy & also predict patients who might respond to a particular treatment.
Scientists develop a pioneering new methodology to study immune cells within tumor using transcriptomic profiling. They show how immune cells can be both good and bad in different cancers. This could aid in improving immunotherapy & also predict patients who might respond to a particular treatment.
No comments:
Post a Comment